AZULTIS Trademark
Trademark Overview
On Friday, April 7, 2023, a trademark application was filed for AZULTIS with the United States Patent and Trademark Office. The USPTO has given the AZULTIS trademark a serial number of 97877494. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 17, 2024. This trademark is owned by PROVEPHARM LIFE SOLUTIONS. The AZULTIS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive
system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of
gynecological and urological systems by instillation, injection or local application; chemical preparations for medical use for
marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable
administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological
systems by instillation, injection or local application; injectable pharmaceutical solutions for use as a marker during gastrointestinal endoscopy; injectable pharmaceutical solutions used as a contrast solution for medical imaging procedures; injectable
pharmaceutical solutions for medical diagnostic purposes for viewing and marking tissu...
General Information
| Serial Number | 97877494 |
| Word Mark | AZULTIS |
| Filing Date | Friday, April 7, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 17, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive
system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of
gynecological and urological systems by instillation, injection or local application; chemical preparations for medical use for
marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable
administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological
systems by instillation, injection or local application; injectable pharmaceutical solutions for use as a marker during gastrointestinal endoscopy; injectable pharmaceutical solutions used as a contrast solution for medical imaging procedures; injectable
pharmaceutical solutions for medical diagnostic purposes for viewing and marking tissue; injectable pharmaceutical solutions
used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas;
injectable pharmaceutical solutions used for polyps or lesions resection medicines for tissue staining; injectable pharmaceutical
solutions for use as a marker during visceral surgery; injectable pharmaceutical solutions for the detection of amniotic fluid leaks;
injectable pharmaceutical solutions for use as a marker during cystoscopy and ureteral catheterization; injectable pharmaceutical
solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; synthetic
peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics;
phytotherapy preparations for medical use; diagnostic preparations in vials for medical use; drug delivery agents in the form of
injectable compounds being pharmaceutical solutions in pre-filled vials that facilitate the delivery of pharmaceutical preparations;
pre-filled syringes for medical and clinical purposes, sold filled with injectable pharmaceutical solutions for marking tissue by
injection application in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable, for the
antiseptic treatment orally or topically, for marking and functional verification gynecological and urological systems, by instillation,
injection or local application |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 2, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | PROVEPHARM LIFE SOLUTIONS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Marseille 13013
FR |
| Party Name | PROVEPHARM LIFE SOLUTIONS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Marseille 13013
FR |
Trademark Events
| Event Date | Event Description |
| Thursday, January 4, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 11, 2023 | NEW APPLICATION ENTERED |
| Tuesday, May 2, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 16, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 16, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 16, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, August 10, 2024 | ASSIGNED TO LIE |
| Sunday, August 11, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, August 11, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 12, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
